Ionis Pharmaceuticals, Inc.
IONS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$453,897 | -$366,286 | -$269,722 | -$28,597 |
| Dep. & Amort. | $19,654 | $22,498 | $22,105 | $19,560 |
| Deferred Tax | $0 | $0 | $0 | $25,311 |
| Stock-Based Comp. | $130,200 | $105,809 | $100,264 | $120,678 |
| Change in WC | -$209,390 | -$77,260 | $7,571 | -$113,818 |
| Other Non-Cash | $12,486 | $7,726 | -$134,588 | $7,665 |
| Operating Cash Flow | -$500,947 | -$307,513 | -$274,370 | $30,799 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$45,280 | -$23,805 | -$20,099 | -$17,901 |
| Net Acquisitions | $0 | $22 | $254,083 | $5,946 |
| Inv. Purchases | -$1,852,858 | -$1,770,814 | -$1,485,772 | -$1,131,378 |
| Inv. Sales/Matur. | $1,769,172 | $1,584,676 | $989,152 | $1,344,185 |
| Other Inv. Act. | -$5,061 | -$4,206 | $0 | -$5,946 |
| Investing Cash Flow | -$134,027 | -$214,127 | -$262,636 | $194,906 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$44,671 | $86,897 | -$50,686 | $313,570 |
| Stock Issued | $522,729 | $49,442 | $6,373 | $11,565 |
| Stock Repurch. | $0 | $0 | -$10,953 | -$16,725 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $507,743 | -$10,982 | -$79,202 |
| Financing Cash Flow | $478,058 | $644,082 | -$55,295 | $245,933 |
| Forex Effect | -$273 | $352 | -$418 | -$111 |
| Net Chg. in Cash | -$157,189 | $122,794 | -$592,719 | $471,527 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $399,266 | $276,472 | $869,191 | $397,664 |
| End Cash | $242,077 | $399,266 | $276,472 | $869,191 |
| Free Cash Flow | -$546,227 | -$335,524 | -$294,469 | $12,898 |